| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.09 | 0.00 (-4.44%) | 0.021 - 0.31 | 10.1 thousand (Below Avg) |
Market data as of 10:51AM 05/20/13. Quotes are delayed by at least 15 min.
| Open | 0.09 |
|---|---|
| Previous Close | 0.09 |
| Day's Range | 0.09 - 0.09 |
| Market Cap | 3.7M |
| Avg Volume (10 Day) | 64.5K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.19 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Fail |
No news headlines available for NLTX
| NLTX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|---|---|
| 7.00 | +3.70% | |
| Aastrom Biosciences Inc | 0.59 | +2.63% |
| Cardiome Pharma Corp | 2.08 | -3.26% |
| Strategic Diagnostics Inc | 1.05 | -0.94% |
| BioSante Pharmaceuticals Inc | 1.15 | +0.88% |
Data is delayed by at least 15 min.